SASharmila Anandasabapathy

Sharmila Anandasabapathy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sharmila Anandasabapathy has a total of 155 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Developing the OpenFlexure Microscope towards medical use: technical and social challenges of developing globally accessible hardware for healthcare

    by Joe Knapper, Freya Whiteford, Daniel Rosen, William Wadsworth, Julian Stirling, Catherine Mkindi, Joram Mduda, Valerian L. Sanga, Paul T. Nyakyi, Thomas Hervé Mboa Nkoudou, et al.

    The OpenFlexure Microscope is an accessible, three-dimensional-printed robotic microscope, with sufficient image quality to resolve diagnostic features including parasites and cancerous cells. As access to lab-grade microscopes is a major challenge in global healthcare, the OpenFlexure Microscope has been developed to be manufactured, maintained and used in remote environments, supporting point-of-care diagnosis. The steps taken in transforming the hardware and software from an academic prototype towards an accepted medical device include addressing technical and social challenges, and are key for any innovation targeting improved effectiveness in low-resource healthcare. This article is part of the Theo Murphy meeting issue 'Open, reproducible hardware for microscopy'.


  • Open Access

    Gambian Mothers Lack Obstetric Danger Sign Knowledge, But Educational Intervention Shows Promise

    by Kara Shannon, Jocelyn Burridge, Brodus Franklin, Sheena Bhushan, Susan Hilsenbeck, Elena V. Petrova, James N’dOw, Ibezimako Iwuh, Sharmila Anandasabapathy, Jeffrey P. Wilkinson

    Annals of Global Health is a peer-reviewed, fully open access, online journal dedicated to publishing high quality articles dedicated to all aspects of global health. The journal's mission is to advance global health, promote research, and foster the prevention and treatment of disease worldwide. Its goals are to improve the health and well-being of all people, advance health equity, and promote wise stewardship of the earth's environment. The latest journal impact factor is 2.90. Annals of Global Health is supported by the Program for Global Public Health and the Common Good at Boston College. It was founded in 1934 by the Icahn School of Medicine at Mount Sinai as the Mount Sinai Journal of Medicine. It is a partner journal of the Consortium of Universities for Global Health. From time to time, Annals of Global Health publishes Special Collections, a series of articles organized around a common theme in global health. Recent Special Collections have included "Local evidence and strategies in addressing NCDs Non-Communicable Diseases in Tanzania", "Universal Health Coverage through Integrated Care", and "The Minderoo-Monaco Commission on Plastics and Human Health". Global health workers interested in developing a Special Collection are strongly encouraged to contact the Managing Editor in advance to discuss the project.


  • Open Access

    A Community-Based Management of COVID-19 in a Mobile Container Unit

    by Elena Petrova, Timothy Farinholt, Tejas P. Joshi, Hannah Moreno, Mayar Al Mohajer, Shital M. Patel, Joseph Petrosino, Sharmila Anandasabapathy

    Vaccine uptake is a multifactor measure of successful immunization outcomes that includes access to healthcare and vaccine hesitancy for both healthcare workers and communities. The present coronavirus disease (COVID-19) pandemic has highlighted the need for novel strategies to expand vaccine coverage in underserved regions. Mobile clinics hold the promise of ameliorating such inequities, although there is a paucity of studies that validate environmental infection in such facilities. Here, we describe community-based management of COVID-19 through a Smart Pod mobile clinic deployed in an underserved community area in the United States (Aldine, Harris County, TX, USA). In particular, we validate infection control and biological decontamination of the Smart Pod by testing surfaces and the air-filtration system for the COVID-19 virus and bacterial pathogens. We show the Smart Pod to be efficacious in providing a safe clinical environment for vaccine delivery. Moreover, in the Smart Pod, up-to-date education of community healthcare workers was provided to reduce vaccine hesitancy and improve COVID-19 vaccine uptake. The proposed solution has the potential to augment existing hospital capacity and combat the COVID-19 pandemic locally and globally.


  • Open Access

    Photoacoustic Imaging in Gastroenterology: Advances and Needs

    by Sheena Bhushan, Sharmila Anandasabapathy, Elena Petrova

    Gastroenterologists routinely use optical imaging and ultrasound for the minimally invasive diagnosis and treatment of chronic inflammatory diseases and cancerous tumors in gastrointestinal tract and related organs. Recent advances in gastroenterological photoacoustics represent combination of multispectral and multiscale photoacoustic (PA), ultrasound (US), and near-infrared (NIR) fluorescent imaging. The novel PA endoscopic methods have been evaluated in preclinical models using catheter-based miniature probes either noncontact, all-optical, forward-viewing probe or contact, side-viewing probe combined with ultrasound (esophagus and colon). The deep-tissue PA tomography has been applied to preclinical research on targeted contrast agents (pancreatic cancer) using benchtop experimental setups. The clinical studies engaging human tissue ex vivo have been performed on endoscopic mucosal resection tissue with PA-US tomography system and intraoperative imaging of pancreatic tissue with PA and NIR fluorescence multimodality. These emerging PA methods are very promising for early cancer detection and prospective theranostics. The noninvasive transabdominal examination with PA-US handheld probe has been implemented into clinical trials for the assessment of inflammatory bowel disease. To facilitate translational and clinical research in PA imaging in gastroenterology, we discuss potential clinical impact and limitations of the proposed solutions and future needs.


  • Remote Laboratory Management: Respiratory Virus Diagnostics

    by Elena V. Petrova, Vasanthi Avadhanula, Sarah Michel, Karen E. Gincoo, Pedro A. Piedra, Sharmila Anandasabapathy

    An uptick in recent pandemics (Ebola, Zika, MERS, influenza, etc.) underlines the need for a more 'nimble,' coordinated response that addresses a multitude of issues ranging from transportation, access, facilities, equipment, and communication to provider training. To address this need, we have developed an innovative, scalable, logistics-enhanced, mobile, laboratory facility for emergencies and epidemics in resource-constrained global settings. Utilizing a background in clinical operations as an academic medical center, we designed a rapidly-deployable, modular BSL-2 and BSL-3 facility with user-friendly software for tracking and management of drugs and supplies in remote regions during epidemics and outbreaks. Here, we present our intermodal, mobile, expandable shipping-container laboratory units. The design of the laboratory facilitates off-grid usage by minimizing power consumption and allowing alternate water sources. The unit's information communication technology (ICT) platform provides (i) user-friendly tablet-based documentation, (ii) enhanced tracking of patients and supplies, and (iii) integrated communication onsite with built-in telehealth capabilities. To ensure quality in remote environments, we have developed a checklist for a basic laboratory workflow and a protocol for respiratory viral diagnosis using reverse-transcription polymerase chain reaction (RT-PCR). As described, this innovative and comprehensive approach allows for the provision of laboratory capability in resource-limited global environments.


  • A Multicenter Study of a Fluorescence In Situ Hybridization Probe Set for Diagnosing High-Grade Dysplasia and Adenocarcinoma in Barrett’s Esophagus

    by John M. Poneros, Adam S. Faye, Emily G. Barr Fritcher, Ananda Sen, Sharmila Anandasabapathy, Robert S. Bresalier, Norman Marcon, D. Kim Turgeon, Henry Appelman, Daniel Normolle, et al.

    Background and Aims Preliminary single-institution data suggest that fluorescence in situ hybridization (FISH) may be useful for detecting high-grade dysplasia (HGD) and esophageal adenocarcinoma (EA) in patients with Barrett’s esophagus (BE). This multicenter study aims to validate the measurement of polysomy (gain of at least two loci) by FISH as a way to discriminate degrees of dysplasia in BE specimens. Methods Tissue specimens were collected from four different hospitals and read by both the local pathology department (“Site diagnosis”) and a single central pathologist (“Review diagnosis”) at a separate institution. The specimens then underwent FISH analysis using probes 8q24 (MYC), 9p21 (CDKN2A), 17q12 (ERBB2), and 20q13 (ZNF217) for comparison. A total of 46 non-BE, 42 non-dysplastic specialized intestinal metaplasia (SIM), 23 indefinite-grade dysplasia (IGD), 10 low-grade dysplasia (LGD), 29 HGD, and 42 EA specimens were analyzed. Results We found that polysomy, as detected by FISH, was the predominant chromosomal abnormality present as dysplasia increased. Polysomy was also the best predictor for the presence of dysplasia or EA when comparing its area under the curve to that of other FISH abnormalities. We observed that if at least 10% of cells had polysomy within a specimen, the FISH probe was able to differentiate between EA/HGD and the remaining pathologies with a sensitivity of 80% and a specificity of 88%. Conclusions This study demonstrates that using FISH to determine the percentage of cells with polysomy can accurately and objectively aid in the diagnosis of HGD/EA in BE specimens.


  • In Vivo Agents and Markers for Endomicroscopy

    by Daniel P. Perl, Sharmila Anandasabapathy

  • 238 Accuracy, Yield and Clinical Impact of a Low-Cost High Resolution Microendoscope in the Early Diagnosis of Esophageal Adenocarcinoma

    by Nabil M. Mansour, Michelle H. Lee, Neil Parikh, Ritu Agarwal, Anoop Prabhu, David M. Henke, Rebecca R. Richards-Kortum, Sharmila Anandasabapathy

  • 235 Accuracy of Post-Hoc High-Resolution Microendoscopy for Diagnosis of Esophageal Squamous Cell Neoplasia

    by Mimi C. Tan, Timothy Quang, Kalpesh K. Patel, Richard A. Schwarz, Chin Hur, Fan Zhang, Yu Xinying, Jason K. Hou, Mohamed O. Othman, Lubin F. Arevalo, et al.

  • Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial

    by Marion-Anna Protano, Hong Xu, Guiqi Wang, Alexandros D. Polydorides, Sanford M. Dawsey, Junsheng Cui, Liyan Xue, Fan Zhang, Timothy Quang, Mark C. Pierce, et al.